Frontlight ResearchEarly access
Alzheimer disease trials, also abroad
822 open Alzheimer disease trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| United States | 361 |
| China | 134 |
| France | 85 |
| Italy | 60 |
| Canada | 58 |
| All other countries |
The same trial often runs in several countries
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) has 2 sites in Switzerland and runs in 14 countries. If a site near you is full, another one may still take people.
See A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) in all 14 countries